Literature DB >> 33743652

A rise in births following contraceptive failure in France between 2010 and 2016: results from the French national perinatal surveys.

Camille Bonnet1, Béatrice Blondel2, Caroline Moreau3,4.   

Abstract

BACKGROUND: In France, while the prevalence of contraception is high, a significant proportion of pregnancies are unintended. Following the 2012 pill scare, the contraceptive method mix, which was mostly comprised of pills and intrauterine devices (IUD), has become more diversified. In this changing landscape, our objective was to describe trends in live births resulting from contraceptive failure and evaluate how patterns of contraceptive use have contributed to observed changes between 2010 and 2016.
METHODS: We used data from the 2010 and the 2016 French National Perinatal surveys which included all births from all maternity units in France over a one-week period. Interviews collecting information about pre-conception contraceptive practices were conducted in the maternity ward post-delivery. Women were classified as having a contraceptive failure if they discontinued contraception because they were pregnant. Our study sample included adult women who had a live birth, had ever used contraception and did not undergo infertility treatment (n = 11,590 in 2010 and n = 9703 in 2016). We evaluated changes in contraceptive failure over time using multivariate Poisson regressions to adjust for sociodemographic characteristics and pre-pregnancy contraceptive methods.
RESULTS: Pre-pregnancy contraception evolved between 2010 and 2016 with a 12.3% point-drop in pill use, and conversely, 4.6%- and 3.2%-point increases in IUD and condom use, respectively. Use of other barrier or natural methods doubled between 2010 and 2016 but remained marginal (1.4% in 2010 vs 3.6% in 2016). Between 2010 and 2016, the proportion of live births resulting from contraceptive failure rose from 7.8 to 10.0%, with higher risks among younger, parous and socially disadvantaged mothers. The risk ratio of contraceptive failure in 2016 compared to 2010 remained higher after sociodemographic adjustments (aRR = 1.34; 95% CI; 1.23-1.47) and after adjusting for pre-pregnancy contraceptive method mix (aRR = 1.35; 95% CI; 1.25-1.49). Increases in contraceptive failures were concentrated among pill and condom users.
CONCLUSIONS: Recent shifts in contraceptive behaviors in France following the 2012 pill scare may be associated with a subsequent increase in births resulting from short acting contraceptives failures.

Entities:  

Keywords:  Contraceptive behaviors; Contraceptive failure; France; Perinatal survey; Pill scare

Mesh:

Substances:

Year:  2021        PMID: 33743652      PMCID: PMC7981992          DOI: 10.1186/s12905-021-01255-y

Source DB:  PubMed          Journal:  BMC Womens Health        ISSN: 1472-6874            Impact factor:   2.809


  19 in total

1.  Trends in perinatal health in metropolitan France from 1995 to 2016: Results from the French National Perinatal Surveys.

Authors:  B Blondel; B Coulm; C Bonnet; F Goffinet; C Le Ray
Journal:  J Gynecol Obstet Hum Reprod       Date:  2017-10-11

2.  Declines in Unintended Pregnancy in the United States, 2008-2011.

Authors:  Lawrence B Finer; Mia R Zolna
Journal:  N Engl J Med       Date:  2016-03-03       Impact factor: 91.245

3.  Patterns of contraceptive use before and after an abortion: results from a nationally representative survey of women undergoing an abortion in France.

Authors:  Caroline Moreau; James Trussell; Julie Desfreres; Nathalie Bajos
Journal:  Contraception       Date:  2010-04-21       Impact factor: 3.375

Review 4.  The birth control pill, thromboembolic disease, science and the media: a historical review of the relationship.

Authors:  Elyse Lackie; Amy Fairchild
Journal:  Contraception       Date:  2016-06-22       Impact factor: 3.375

5.  Trends and determinants of use of long-acting reversible contraception use among young women in France: results from three national surveys conducted between 2000 and 2010.

Authors:  Caroline Moreau; Aline Bohet; Danielle Hassoun; Michel Teboul; Nathalie Bajos
Journal:  Fertil Steril       Date:  2013-05-10       Impact factor: 7.329

6.  Typical-use contraceptive failure rates in 43 countries with Demographic and Health Survey data: summary of a detailed report.

Authors:  Chelsea B Polis; Sarah E K Bradley; Akinrinola Bankole; Tsuyoshi Onda; Trevor Croft; Susheela Singh
Journal:  Contraception       Date:  2016-03-24       Impact factor: 3.375

7.  Contraceptive Failure in the United States: Estimates from the 2006-2010 National Survey of Family Growth.

Authors:  Aparna Sundaram; Barbara Vaughan; Kathryn Kost; Akinrinola Bankole; Lawrence Finer; Susheela Singh; James Trussell
Journal:  Perspect Sex Reprod Health       Date:  2017-02-28

8.  Short interpregnancy intervals and adverse maternal outcomes in high-resource settings: An updated systematic review.

Authors:  Jennifer A Hutcheon; Heidi D Nelson; Reva Stidd; Susan Moskosky; Katherine A Ahrens
Journal:  Paediatr Perinat Epidemiol       Date:  2018-10-12       Impact factor: 3.980

9.  Hormonal contraception and risk of venous thromboembolism: national follow-up study.

Authors:  Øjvind Lidegaard; Ellen Løkkegaard; Anne Louise Svendsen; Carsten Agger
Journal:  BMJ       Date:  2009-08-13

10.  Short interpregnancy intervals and adverse perinatal outcomes in high-resource settings: An updated systematic review.

Authors:  Katherine A Ahrens; Heidi Nelson; Reva L Stidd; Susan Moskosky; Jennifer A Hutcheon
Journal:  Paediatr Perinat Epidemiol       Date:  2018-10-24       Impact factor: 3.980

View more
  2 in total

1.  Results of the National Contraception Survey Conducted by Sociedad Española de Contracepción (2020).

Authors:  Fatima Leon-Larios; José Gutiérrez Ales; María José Puente Martínez; Marta Correa Rancel; Isabel Lahoz Pascual; Isabel Silva Reus; José Cruz Quílez Conde
Journal:  J Clin Med       Date:  2022-06-29       Impact factor: 4.964

2.  Exploring rise of pregnancy in Bangladesh resulting from contraceptive failure.

Authors:  Md Nuruzzaman Khan; M Mofizul Islam
Journal:  Sci Rep       Date:  2022-02-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.